{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:35:31Z","timestamp":1793151331981,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RE 4598\/1\\u20132"],"award-info":[{"award-number":["RE 4598\/1\\u20132"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002977","name":"Dalhousie University - Halifax Campus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003331","name":"Provincial Health Services Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011775","name":"BC Children\u2019s Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vaccine.2024.05.052","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:56:39Z","timestamp":1716670599000},"page":"126004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021\u20132023 in Vancouver metropolitan area, British Columbia, Canada"],"prefix":"10.1016","volume":"42","author":[{"given":"Frederic","family":"Reicherz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-7030","authenticated-orcid":false,"given":"Allison A.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-9504","authenticated-orcid":false,"given":"David M.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2205-0362","authenticated-orcid":false,"given":"Pascal M.","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Abu-Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.05.052_b0005","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/cid\/cis287","article-title":"Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak","volume":"54","author":"Witt","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0010","doi-asserted-by":"crossref","first-page":"e20153326","DOI":"10.1542\/peds.2015-3326","article-title":"Waning Tdap effectiveness in adolescents","volume":"137","author":"Klein","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.05.052_b0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12916-015-0382-8","article-title":"Asymptomatic transmission and the resurgence of Bordetella pertussis","volume":"13","author":"Althouse","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2024.05.052_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/jpids\/piy128","article-title":"Burden of children hospitalized with pertussis in Canada in the acellular pertussis vaccine era, 1999\u20132015","volume":"9","author":"Abu-Raya","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2024.05.052_b0025","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMcp041025","article-title":"Clinical practice. Pertussis\u2013not just for kids","volume":"352","author":"Hewlett","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.05.052_b0030","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40121-021-00440-8","article-title":"Bordetella pertussis in school-age children, adolescents, and adults: a systematic review of epidemiology, burden, and mortality in the middle east","volume":"10","author":"Macina","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.05.052_b0035","unstructured":"Centers for Disease Control and Prevention. Available at:https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/pert.html. Accessed on August 1st, 2023.."},{"key":"10.1016\/j.vaccine.2024.05.052_b0040","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/infdis\/jiac192","article-title":"Waning immunity against respiratory syncytial virus during the coronavirus disease 2019 pandemic","volume":"226","author":"Reicherz","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.29.2100639","article-title":"Low levels of respiratory syncytial virus activity in Europe during the 2020\/21 season: what can we expect in the coming summer and autumn\/winter?","volume":"26","author":"van Summeren","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.05.052_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2022.04.086","article-title":"Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures","author":"Reicherz","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.052_b0055","unstructured":"BC centre for disease control. British Columbia Provincial Pertussis Summary.September 6, 2023. Available at: http:\/\/www.bccdc.ca\/resourcegallery\/Documents\/BC%20Provincial%20Pertussis%20Summary%20Final.pdf. Accessed on December 16, 2023.."},{"key":"10.1016\/j.vaccine.2024.05.052_b0060","doi-asserted-by":"crossref","first-page":"e071228","DOI":"10.1136\/bmjopen-2022-071228","article-title":"SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia","volume":"13","author":"Watts","year":"2023","journal-title":"Canada BMJ Open"},{"key":"10.1016\/j.vaccine.2024.05.052_b0065","doi-asserted-by":"crossref","first-page":"e057846","DOI":"10.1136\/bmjopen-2021-057846","article-title":"SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study","volume":"12","author":"Goldfarb","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2024.05.052_b0070","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","article-title":"What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories","volume":"30","author":"Guiso","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0075","unstructured":"World Health Organization. WHO Technical Report, Series No. 924, 2004. Annex 1. Guidelines on clinical evaluation of vaccines: regulatory expectations. Available at: https:\/\/cdn.who.int\/media\/docs\/default-source\/biologicals\/vaccine-quality\/guidelines-on-clinical-evaluation-of-vaccines-regulatory-expectations867c9e6a-f022-47e6-986e-235fbc274b0f.pdf?sfvrsn=40d99bd4_1&download=true . Accessed on April 14, 2024. ."},{"key":"10.1016\/j.vaccine.2024.05.052_b0080","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10096-001-0639-3","article-title":"Stability of antibodies to Bordetella antigens in German adults","volume":"20","author":"Saemann-Ischenko","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/313913","article-title":"Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents","volume":"31","author":"Hodder","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0090","first-page":"45","article-title":"Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland","volume":"2021","author":"Adegbija","year":"2018","journal-title":"Australia Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2024.05.052_b0095","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1093\/cid\/ciaa1682","article-title":"Impact of nonpharmaceutical interventions on the incidence of respiratory infections during the coronavirus disease 2019 (COVID-19) outbreak in Korea: A nationwide surveillance study","volume":"72","author":"Huh","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0100","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/jmv.26614","article-title":"Impact of social distancing on incidence of vaccine-preventable diseases","volume":"93","author":"Yun","year":"2021","journal-title":"South Korea J Med Virol"},{"key":"10.1016\/j.vaccine.2024.05.052_b0105","article-title":"Waning infant pertussis during COVID-19 pandemic","author":"Falkenstein-Hagander","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2024.05.052_b0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12889-022-12830-9","article-title":"Impact of the COVID-19 pandemic on Bordetella pertussis infections in England","volume":"22","author":"Tessier","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2024.05.052_b0115","article-title":"Pertussis deaths in New Zealand without community transmission-an infant immunity gap?","volume":"37","author":"McIntyre","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2024.05.052_b0120","article-title":"Clarifying pertussis in Denmark","author":"Dalby","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0125","unstructured":"INCREASE IN CASES OF PERTUSSIS . Risk Assessment Group. Available at: https:\/\/www.sciensano.be\/sites\/default\/files\/20231002_rag_pra_pertussis.pdf . Accessed on December 30 th , 2023."},{"key":"10.1016\/j.vaccine.2024.05.052_b0130","doi-asserted-by":"crossref","DOI":"10.1007\/s40121-023-00895-x","article-title":"Assessing the underestimation of adult pertussis disease in five latin American countries","author":"Guzman-Holst","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2024.05.052_b0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/504803","article-title":"Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)","volume":"43","author":"Ward","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/cid\/ciz531","article-title":"Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review","volume":"70","author":"Craig","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.05.052_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1073\/pnas.1314688110","article-title":"Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model","volume":"111","author":"Warfel","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.05.052_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41541-020-00270-8","article-title":"Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage","volume":"6","author":"Dubois","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2024.05.052_b0155","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1080\/21645515.2020.1844505","article-title":"A systematic review of the burden of pertussis in South Korea","volume":"17","author":"Mungall","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.05.052_b0160","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.3346\/jkms.2018.33.e321","article-title":"Seroprevalence of pertussis in healthcare workers without adult pertussis vaccine use at a university hospital in Korea","volume":"33","author":"Choi","year":"2018","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.vaccine.2024.05.052_b0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4161\/hv.36167","article-title":"Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain","volume":"11","author":"Urbiztondo","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.05.052_b0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/apm.13165","article-title":"Pertussis seroprevalence among adults of reproductive age (20\u201339 years) in fourteen European countries","volume":"129","author":"Wehlin","year":"2021","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2024.05.052_b0175","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1016\/j.vaccine.2022.10.020","article-title":"The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: A cross-sectional sero-epidemiological study","volume":"40","author":"He","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.05.052_b0180","doi-asserted-by":"crossref","unstructured":"Chen Z, Pang J, Zhang Y, Ding Y, Chen N, Zhang N, et al. Seroprevalence of pertussis in adults at childbearing age pre- and post- COVID-19 in Beijing, China. Vaccines (Basel). 2022;10.","DOI":"10.3390\/vaccines10060872"},{"key":"10.1016\/j.vaccine.2024.05.052_b0185","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/fmb.09.133","article-title":"Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools","volume":"5","author":"Carbonetti","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2024.05.052_b0190","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1093\/cid\/cix691","article-title":"A population-based study of recurrent symptomatic bordetella pertussis infections in children in California, 2010\u20132015","volume":"65","author":"Platt","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24006200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:09:01Z","timestamp":1737583741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24006200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0264410X24006200"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bordetella pertussis infection following relaxation of COVID-19 non-pharmaceutical interventions in 2021\u20132023 in Vancouver metropolitan area, British Columbia, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126004"}}